Compare Cassava Sciences Inc (FLNA) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs First Trust Cloud Computing ETF — how do they compare? Cassava Sciences Inc trades at $0.83 (market cap $39.40M), while First Trust Cloud Computing ETF trades at $172.56 (market cap $3.47B). The key difference: First Trust Cloud Computing ETF is far larger — about 88.1× Cassava Sciences Inc's market cap, and First Trust Cloud Computing ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and First Trust Cloud Computing ETF for 84 Days on average.
| FLNA | SKYY | |
|---|---|---|
Market Cap | $39.40M | $3.47B |
Volume | 759,018 | 176,159 |
Sector | Health | — |
52-Week High | $4.64 | $171.01 |
52-Week Low | $0.68 | $104.16 |
Typical Hold Time | 37 Days | 84 Days |
Enterprise Value | -$43.28M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Filana Therapeutics (FLNA) trades at $0.82, down 6.77% today, amid bearish technical signals but with positive fundamental catalysts. The company shows improving quarterly EPS beats and a favorable EV/EBITDA of 1.03, though it remains unprofitable with negative cash flow. Recent FDA clearance for its epilepsy drug trial has generated optimism, reflected in strong analyst buy ratings (67% consensus).
The outlook balances clinical progress against financial strain. The FDA hold lift on simufilam provides a clear near-term catalyst for Phase 2a trials starting in 2027, supporting the bullish analyst view. However, high cash burn (-$33M net CF in 2025) and lack of revenue pose significant risks to sustainability, requiring careful monitoring of funding and trial milestones.
SKYY (First Trust Cloud Computing ETF) trades at $171.75, up 0.57% today and recently hitting a new 52-week high. Technical indicators show a bullish trend with strong moving average support, while oscillators remain neutral. The ETF benefits from strong secular trends in cloud computing and AI infrastructure spending, with recent news highlighting institutional position adjustments and positive sector outlook.
The outlook remains positive given cloud computing's growth trajectory and AI-driven demand, though valuation metrics are unavailable for analysis. Risks include sector concentration and market volatility. Institutional activity shows mixed signals with some trimming positions while sector analysts maintain optimistic coverage on cloud computing infrastructure growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
